Ackerman Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $499K | Buy |
1,966
+53
| +3% | +$12.4K | 0.1% | 74 |
|
|
2026
Q1 | $468K | Hold |
1,913
| – | – | 0.1% | 76 |
|
|
2025
Q4 | $396K | Hold |
1,913
| – | – | 0.08% | 83 |
|
|
2025
Q3 | $355K | Hold |
1,913
| – | – | 0.07% | 83 |
|
|
2025
Q2 | $292K | Buy |
1,913
+13
| +0.7% | +$2K | 0.07% | 88 |
|
|
2025
Q1 | $315K | Hold |
1,900
| – | – | 0.08% | 79 |
|
|
2024
Q4 | $275K | Hold |
1,900
| – | – | 0.07% | 87 |
|
|
2024
Q3 | $308K | Hold |
1,900
| – | – | 0.08% | 81 |
|
|
2024
Q2 | $278K | Hold |
1,900
| – | – | 0.07% | 85 |
|
|
2024
Q1 | $301K | Hold |
1,900
| – | – | 0.08% | 85 |
|
|
2023
Q4 | $298K | Hold |
1,900
| – | – | 0.08% | 86 |
|
|
2023
Q3 | $296K | Hold |
1,900
| – | – | 0.08% | 78 |
|
|
2023
Q2 | $314K | Hold |
1,900
| – | – | 0.08% | 80 |
|
|
2023
Q1 | $295K | Hold |
1,900
| – | – | 0.08% | 80 |
|
|
2022
Q4 | $336K | Hold |
1,900
| – | – | 0.09% | 78 |
|
|
2022
Q3 | $310K | Sell |
1,900
-300
| -14% | -$50.8K | 0.09% | 79 |
|
|
2022
Q2 | $391K | Hold |
2,200
| – | – | 0.11% | 73 |
|
|
2022
Q1 | $390K | Hold |
2,200
| – | – | 0.09% | 80 |
|
|
2021
Q4 | $376K | Sell |
2,200
-3,376
| -61% | -$553K | 0.09% | 82 |
|
|
2021
Q3 | $901K | Hold |
5,576
| – | – | 0.21% | 46 |
|
|
2021
Q2 | $919K | Hold |
5,576
| – | – | 0.22% | 42 |
|
|
2021
Q1 | $916K | Hold |
5,576
| – | – | 0.22% | 45 |
|
|
2020
Q4 | $878K | Sell |
5,576
-2,400
| -30% | -$354K | 0.22% | 43 |
|
|
2020
Q3 | $1.19M | Hold |
7,976
| – | – | 0.33% | 33 |
|
|
2020
Q2 | $1.12M | Hold |
7,976
| – | – | 0.34% | 32 |
|
|
2020
Q1 | $1.05M | Buy |
7,976
+608
| +8% | +$86.3K | 0.41% | 29 |
|
|
2019
Q4 | $1.07M | Sell |
7,368
-191
| -3% | -$25.9K | 0.32% | 43 |
|
|
2019
Q3 | $978K | Buy |
7,559
+164
| +2% | +$21.6K | 0.34% | 44 |
|
|
2019
Q2 | $1.03K | Sell |
7,395
-397
| -5% | -$55K | 0.01% | 79 |
|
|
2019
Q1 | $1.09K | Buy |
7,792
+3
| +0% | +$402 | 0.01% | 78 |
|
|
2018
Q4 | $1K | Buy |
+7,789
| New | +$1.09M | 0.08% | 80 |
|
|
2018
Q1 | $1.55M | Sell |
11,109
-20
| -0.2% | -$2.7K | 0.62% | 29 |
|
|
2017
Q4 | $1.45M | Buy |
+11,129
| New | +$1.55M | 0.61% | 26 |
|
|
2017
Q2 | $1.47M | Buy |
+11,126
| New | +$1.42M | 0.62% | 30 |
|
Other funds holding JNJ
Ackerman Capital Advisors's JNJ Position: Q2 2026 in Review
Ackerman Capital Advisors increased its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2026, buying an estimated $12.4K and bringing the position to 1,966 shares worth $499K. The position accounts for 0.1% of the portfolio, ranked #74.
Ackerman Capital Advisors first reported a position in JNJ in Q2 2017 and has held it in 34 quarters since. The position peaked at $1.55M in Q1 2018. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Ackerman Capital Advisors held 1,966 shares of Johnson & Johnson worth $499K as of Q2 2026.
- Ackerman Capital Advisors bought 53 Johnson & Johnson shares in Q2 2026, an estimated $12.4K.
- Johnson & Johnson made up 0.1% of Ackerman Capital Advisors's portfolio in Q2 2026, its #74 holding.
- Ackerman Capital Advisors first reported a position in Johnson & Johnson in Q2 2017 and has held it in 34 quarters since.
- Ackerman Capital Advisors's Johnson & Johnson position peaked at $1.55M in Q1 2018.
- 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Ackerman Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.